Micro-entity Accounts - CELL AND GENE THERAPY LTD.

Micro-entity Accounts - CELL AND GENE THERAPY LTD.

CELL AND GENE THERAPY LTD. - Company Information

Print Friendly Version

Registered Number 09415326

CELL AND GENE THERAPY LTD.

Micro-entity Accounts

31 January 2023

CELL AND GENE THERAPY LTD. Registered Number 09415326

Micro-entity Balance Sheet as at 31 January 2023

Notes 2023 2022
£ £
Fixed Assets
30,757
30,757
Total assets less current liabilities
30,757
30,757
Creditors: amounts falling due after more than one year
(37,960)
(37,960)
Total net assets (liabilities)
(7,203)
(7,203)
Capital and reserves
(7,203)
(7,203)
  • For the year ending 31 January 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
  • The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  • The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
  • The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 2 October 2023

And signed on their behalf by:
Teresa Brewster, Director

CELL AND GENE THERAPY LTD. Registered Number 09415326

Notes to the Micro-entity Accounts for the period ended 31 January 2023

1Employees
2023 2022
Average number of employees during the period 1 1